T1	chemical 42 50	antigens
T2	disease_or_phenotypic_feature 54 67	breast cancer
T3	disease_or_phenotypic_feature 130 136	stroke
T4	chemical 276 281	group
T5	chemical 543 548	group
T6	chemical 602 608	oxygen
T7	disease_or_phenotypic_feature 620 627	(L-SaO2
T8	chemical 708 712	drug
T9	disease_or_phenotypic_feature 723 736	renal failure
T10	chemical 746 749	MDA
T11	chemical 812 819	biology
T12	disease_or_phenotypic_feature 860 866	cancer
T13	chemical 908 916	antigens
T14	disease_or_phenotypic_feature 934 958	hepatocellular carcinoma
T15	disease_or_phenotypic_feature 972 990	Schizophrenia-like
T16	chemical 1031 1040	Melatonin
T17	disease_or_phenotypic_feature 1072 1080	cataract
T18	chemical 1089 1099	anesthesia
T19	disease_or_phenotypic_feature 1147 1152	blood
T20	chemical 1162 1168	oxygen
T21	disease_or_phenotypic_feature 1252 1257	blood
T22	disease_or_phenotypic_feature 1303 1309	injury
T23	chemical 1314 1321	protein
T24	chemical 1353 1366	enzyme-linked
T25	chemical 1467 1474	antigen
T26	disease_or_phenotypic_feature 1490 1496	anemia
T27	disease_or_phenotypic_feature 1674 1683	sensitive
T28	chemical 1713 1716	his
T29	chemical 1780 1787	calcium
T30	disease_or_phenotypic_feature 1798 1811	hypercalcemia
T31	chemical 1848 1859	SP-EPN-MYCN
T32	chemical 2019 2028	molecular
T33	disease_or_phenotypic_feature 2036 2046	ependymoma
T34	chemical 2075 2083	[Alcohol
T35	disease_or_phenotypic_feature 2075 2094	[Alcohol dependence
T36	disease_or_phenotypic_feature 2167 2185	growth retardation
T37	chemical 2237 2246	inhibitor
T38	chemical 2247 2255	orlistat
T39	disease_or_phenotypic_feature 2259 2274	T cell lymphoma
T40	chemical 2376 2386	anesthesia
T41	disease_or_phenotypic_feature 2391 2399	cataract
T42	chemical 2464 2473	inhibitor
T43	chemical 2475 2484	rofecoxib
T44	disease_or_phenotypic_feature 2489 2515	inflammatory bowel disease
T45	disease_or_phenotypic_feature 2538 2547	arthritis
T46	disease_or_phenotypic_feature 2552 2562	arthralgia
T47	disease_or_phenotypic_feature 2578 2584	cancer
T48	chemical 2645 2650	yeast
T49	chemical 2667 2675	antigens
T50	chemical 2709 2716	biology
T51	disease_or_phenotypic_feature 2720 2733	rectal cancer
T52	chemical 2867 2874	protein
T53	disease_or_phenotypic_feature 2947 2962	type 2 diabetes
T54	disease_or_phenotypic_feature 3003 3016	liver disease
T55	missed_disease_or_phenotypic_feature 25 30	tumor
T56	missed_chemical 868 882	Autoantibodies
T57	missed_disease_or_phenotypic_feature 891 896	tumor
R6	causes_or_contributes_to Arg1:T34 Arg2:T35	
T58	corrected_chemical 2217 2246	fatty acid synthase inhibitor
R7	treats Arg1:T38 Arg2:T39	
R8	treats Arg1:T58 Arg2:T39	
T59	corrected_chemical 2446 2473	cyclo-oxygenase-2 inhibitor
R9	treats Arg1:T59 Arg2:T44	
R10	treats Arg1:T43 Arg2:T44	
R11	treats Arg1:T59 Arg2:T45	
R12	treats Arg1:T59 Arg2:T46	
R13	treats Arg1:T43 Arg2:T45	
R14	treats Arg1:T43 Arg2:T46	
T60	DONE 3112 3116	DONE
T61	corrected_disease_or_phenotypic_feature 960 999	Reversal of Schizophrenia-like Symptoms
R3	causes_or_contributes_to Arg1:T16 Arg2:T61	
T62	corrected_disease_or_phenotypic_feature 1004 1027;960 971	Cholinergic Alterations Reversal of
R4	causes_or_contributes_to Arg1:T16 Arg2:T62	
R1	treats Arg1:T16 Arg2:T15	
T63	missed_disease_or_phenotypic_feature 1004 1027	Cholinergic Alterations
R2	treats Arg1:T16 Arg2:T63	
T64	corrected_disease_or_phenotypic_feature 2161 2185	Tumor growth retardation
T65	missed_disease_or_phenotypic_feature 2161 2166;2190 2206	Tumor chemosensitizing
R5	causes_or_contributes_to Arg1:T58 Arg2:T65	
R15	causes_or_contributes_to Arg1:T58 Arg2:T64	
R16	causes_or_contributes_to Arg1:T38 Arg2:T65	
R17	causes_or_contributes_to Arg1:T38 Arg2:T64	
